Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy's Laboratories launching a generic competitor to the London-listed drugmaker's bestselling opioid addiction treatment.
from Reuters: Health News https://ift.tt/2SJ1Rt0
via
IFTTT
0 comments:
Post a Comment